Register for email alerts and news feeds:
This journal | BMJ Group
rss
Evidence-Based Medicine 2006;11:143; doi:10.1136/ebm.11.5.143
Copyright © 2006 by the BMJ Publishing Group Ltd.

Therapeutics

Clopidogrel plus aspirin did not differ from aspirin alone for reducing MI, stroke, and CV death in high risk atherothrombosis

Bhatt DL, Fox KA, Hacke W, et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 2006;354:1706–17.[Abstract/Free Full Text]

Q In patients with high risk atherothrombosis, is long term treatment with clopidogrel plus aspirin more effective than aspirin alone for reducing cardiovascular (CV) events?

Clinical impact ratings GP/FP/Primary care *****{star}{star} IM/Ambulatory care ******{star} Internal medicine ******{star} Neurology ******{star} Cardiology ******{star}

Key Words: aspirin • cardiovascular diseases • platelet aggregation inhibitors • thrombosis • ticlopidine

The first 150 words of the full text of this article appear below.

METHODS

Formula Design: randomised placebo controlled trial (Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilisation, Management, and Avoidance [CHARISMA]).

Formula Allocation: concealed.*

Formula Blinding: blinded {clinicians, patients, data collectors, outcome assessors, data analysts, and data safety and monitoring committee}{dagger}.*

Formula Follow up period: median 28 months.

Formula Setting: 768 sites in 32 countries.

Formula Patients: 15 603 patients >=45 years of age (median age 64 y, 70% men, 80% white) who had multiple atherothrombotic risk factors (type 1 or 2 diabetes, diabetic nephropathy, ankle brachial index <0.9, asymptomatic carotid stenosis >=70% of luminal diameter, >=1 carotid plaque, systolic blood pressure >=150 mm Hg, primary hypercholesterolaemia, smoking >15 cigarettes/d, or men >=65 y or women >=70 y of age), coronary disease, cerebrovascular disease, or symptomatic peripheral arterial disease. Exclusion criteria were long term use of antithrombotic or non-steroidal anti-inflammatory drugs, indications for clopidogrel therapy, or revascularisation.

Formula Intervention: clopidogrel, 75 mg/day, plus aspirin, 75–162 mg/day (n = 7802), . . . [Full text of this article]

Kenneth A Ballew, MD, MS

University of Virginia, Charlottesville, Virginia, USA


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Article

Glossary
Evid. Based Med. 2006 11: 159a. (in Glossary) [Extract] [Full Text] [PDF]

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.